Mealey's Emerging Drugs & Devices
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing firstname.lastname@example.org; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
Mealey's Emerging Drugs & Devices covers cases involving a variety of prescription drugs, implants and medical devices. Antidepressants, atypical antipsychotics, diabetes drugs, statins and anticoagulants are among the drug litigations that are tracked. Medical devices covered include pelvic mesh, metal-on-metal hip prostheses, birth control devices, inferior vena cava filters and artificial knees. Coverage also includes regulatory enforcement of drug and medical device manufacturers, False Claims Act lawsuits and government civil and criminal investigations.
The Report features unbiased news stories, case summaries, attorney listings and the full text of court documents. Subscribers also receive expert commentary articles. Subscribers enjoy comprehensive state and federal trial and appellate courts coverage from start to finish, including pleadings, opinions, jury verdicts, settlements and more. Published twice monthly.
This valuable insight into current news and litigation trends helps subscribers to advise clients, prepare for trial, draft pleadings and briefs, connect with key players in the litigation, gauge the temperament of the judiciary and build compelling cases. Subscribe today!
Email Delivery: Newsletters and breaking news bulletins delivered right to your email inbox with access to daily stories, documents and more. Price includes delivery of three newsletters via email for three unique users each with access to the Report at the www.LexisLegalNews.com service. After placing your order, please expect an email within 24-48 hours with your initial username and password, along with helpful tips to get you started. For additional users or seats, please contact your LexisNexis account representative or call 1.800.223.1940. Learn more or register for a free trial by clicking here.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.